A Novel Approach to Tackling Rare Progressive Muscle Disorders 1 Corporate Presentation May 2022 Disclaimer 2 This presentation contains forward-looking statements that involve substantial risks and uncertainties of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"). All statements other than statements of historical facts contained in this presentation, including statements regarding our future financial condition, results of operations, business strategy and plans, and objectives of management for ...